We investigated the effects of interactions of medetomidine and atipamezole on electroencephalography (EEG) in seven dogs. The dogs were sedated with medetomidine at dose of 30$\mu\textrm{g}$/kg, IM. Atipamezole was injected 15 min later at dose of 30$\mu\textrm{g}$/kg, IV. Recording electrode was positioned at Cz, which was applied to International 10-20 system. Heart rates, arterial blood pressures and behavioral changes were also measured. EEG was recorded in 6 stages(S1: before medetomidine injection, S2: prior to head-down movement after medetomidine injection, S3: 5 minutes after medetomidine injection, S4: 10 minutes after medetomidine injection, S5: 15 minutes after medetomidine injection, S6: prior to head-up movement after atipamezole injection), and heart rates and arterial pressures were recorded at S1, S5 and S6. All results were compared with those of control(S1). After medetomidine injection, the power spectra of EEG were gradually decreased and those of the frequency over 13 Hz were significantly decreased(p<0.05), which were still in the significantly decreased state after atipamezole injection. In the band powers (Band1; 1-2.5 Hz, Band2; 2.5-4.5 Hz, Band3; 4-8Hz, Band4; 8-13 Hz, Band5; 13-20 Hz, Band6; 20-30 Hz, Band7; 30-50 Hz, Band8; 1-50 Hz), band 1, 2, 3, 4, 8 were not significantly changed in any stages. Band 5, 6, 7 were significantly decreased in S 3, 4, 5, 6. That is, medetomidine affects the frequency band over 13 Hz on EEG, and atipamezole does not restored the decreased band powers until dogs showed head-up movement.